Approval Year
| Substance Class |
Nucleic Acid
Created
by
admin
on
Edited
Wed Apr 02 13:17:06 GMT 2025
by
admin
on
Wed Apr 02 13:17:06 GMT 2025
|
| Nucleic Acid Type | OLIGONUCLEOTIDE |
| Sequence Origin | SYNTHETIC |
| Sequence Type | COMPLETE |
| Record UNII |
W6YJ85G6YG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
W6YJ85G6YG
Created by
admin on Wed Apr 02 13:17:06 GMT 2025 , Edited by admin on Wed Apr 02 13:17:06 GMT 2025
|
PRIMARY | |||
|
C188648
Created by
admin on Wed Apr 02 13:17:06 GMT 2025 , Edited by admin on Wed Apr 02 13:17:06 GMT 2025
|
PRIMARY | |||
|
12351
Created by
admin on Wed Apr 02 13:17:06 GMT 2025 , Edited by admin on Wed Apr 02 13:17:06 GMT 2025
|
PRIMARY | |||
|
JK-207
Created by
admin on Wed Apr 02 13:17:06 GMT 2025 , Edited by admin on Wed Apr 02 13:17:06 GMT 2025
|
PRIMARY | |||
|
2589926-20-3
Created by
admin on Wed Apr 02 13:17:06 GMT 2025 , Edited by admin on Wed Apr 02 13:17:06 GMT 2025
|
PRIMARY | |||
|
300000044075
Created by
admin on Wed Apr 02 13:17:06 GMT 2025 , Edited by admin on Wed Apr 02 13:17:06 GMT 2025
|
PRIMARY |
| Sugar | Site Range | Site Count |
|---|---|---|
| D-Ribose (RNA) | 1_4-1_13 | 10 / 16 |
| 1_3;1_14-1_15 | 3 / 16 | |
| 2'-O-Methoxyethyl ribose | 1_1-1_2;1_16 | 3 / 16 |
| Linkage | Site Range | Site Count |
|---|---|---|
| Phosporothioate | 1_2;1_5-1_14;1_16 | 12 / 15 |
| Phosphate | 1_3-1_4;1_15 | 3 / 15 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
The LICA technology incorporated in ION904 a
triantennary N-acetyl galactosamine (GalNAc) moiety which targets the asialoglycoprotein
receptors (ASGPR) expressed abundantly on the hepatocyte cell surface, resulting in antisense mediated inhibition of angiotensinogen (AGT) expression within the hepatocyte
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| NUCLEOSIDE BASE SUBSTITUTION | [1_3] [1_12] [1_13] | 5-METHYLCYTOSINE | 6R795CQT4H | |||
| NUCLEOTIDE SUBSTITUTION | [1_1] | 5'-TERMINUS | ISIS-757456 CYTOSINE PHOSPHATE 5'-MODIFICATION | 49G0W4AL3R |